News

Policy & Practice


 

www.hhs.gov/ocr/privacy

Supplement Maker Fined $70 M

In a case brought by the Federal Trade Commission, a marketing group that used infomercials to tout calcium and herbal supplements as effective treatments for cancer, Parkinson's disease, heart disease, and autoimmune conditions has been ordered to pay about $70 million in consumer refunds. Last year, the U.S. District Court for the District of Massachusetts ruled that the companies and individuals involved in marketing the supplements had falsely represented their safety and efficacy. Judge George O'Toole considered potential financial penalties separately, and has now ordered the restitution in order to strip from the defendants all profits derived from the supplement sales. He also issued injunctions to prevent the defendants from making similar claims about other products.

Pages

Recommended Reading

Certification Plan For Procedural Derm Postponed : Subspecialty proposal opposed by AAD.
MDedge Dermatology
Vital Signs: Helth Care Reform
MDedge Dermatology
Botulinum Toxins Get New Generic Names
MDedge Dermatology
Policy & Practice
MDedge Dermatology
Senate Approves Dr. Collins as NIH Director
MDedge Dermatology
N.Y. Anesthesia Law May Affect Dermatologists
MDedge Dermatology
Vital Signs: Massachusetts Ranked First in E-Prescribing for 2008
MDedge Dermatology
Experts Offer Advice on Complying With the Red Flags Rule
MDedge Dermatology
An Underwater Bond
MDedge Dermatology
Committee Aims to Ease Requirements for EHR Adoption
MDedge Dermatology